SecBot SecBot

Interagency Patent Coordination and Improvement Act of 2025

S. 1097 Sen. Richard Durbin (D-IL) In committee
Bill text PDF
  1. Introduced Mar 24
  2. Committee Mar 24
  3. Passed Senate Next
  4. Passed House Not yet
  5. To President Not yet
  6. Law Not yet
Where it stands
In committee, Mar 24, 2025Next: Senate vote
565d ago Apr 10, 2025: Placed on Senate Legislative Calendar under General Orders. Calendar No. 41.
Final votes
No roll callsNo recorded vote on this bill yet
Lobbying
3companies, 20 filings
Subscribe to see spend
Member trades
7trades in the last 90 days
Subscribe to see who
Who backs the bill and who pushes back Subscribe

Companies lobbying on this bill

3 companies
Companies by sector
Biotech & Pharma 3
Search all 3 companies, their asks and price moves Subscribe

Summary

Interagency Patent Coordination and Improvement Act of 2025

Full summary2 paragraphs

This bill establishes the Interagency Task Force on Patents to support coordination and communication between the U.S. Patent and Trademark Office (USPTO) and the Food and Drug Administration (FDA) on activities relating to patents for human drugs and biological products.

The task force's duties shall include sharing information about (1) the processes of each agency, including how each agency evaluates applications (e.g., patent applications at the USPTO and new drug applications at the FDA); and (2) new approvals of patents, human drugs, biological products, and new technologies. The task force must also establish a process that requires (1) the USPTO to request from the FDA information relating to certain patent applications to help patent examiners carry out their duties, (2) the FDA to provide such information to the USPTO, and (3) the USPTO to assist the FDA in its ministerial role of listing patents.

Library of Congress summary, Mar 24, 2025

Summary versions
  • Introduced in SenateMar 24, 2025

Official record from Congress.gov, the House Clerk and the Senate; lobbying from Lobbying Disclosure Act filings. Updated Oct 27, 2026.